person

Birte Glenthøj, Professor

Birte Glenthøj, MD, MSc
as of 2026-07-01
at a glance
Roles: Study Chair, Study Director, Author, Investigator+Author
KOL signal score 19
7 publications · 3 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.

Profile

Affiliation
Capital Mental Health Services, Center for Neuropsykiatrisk Skizofreniforskning, CNSR & Lundbeck Foundation Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS
Roles
Study Chair, Study Director, Author, Investigator+Author
KOL signal
19
Publications
7 (3 high-value)
Trial investigator
yes

Publishes on

1 drugs

Trials led

4

Publications & congress

6
High-Dose Vitamin D3 Supplementation During Pregnancy and Test-Based Cognitive Performance at Age 10 Years: A Post Hoc Secondary Analysis of a Randomized Clinical Trial.
JAMA network open · 2026 · high-value
Symptom Network Dynamics during Antipsychotic Treatment in First-Episode Psychosis.
Schizophrenia bulletin · 2026 · high-value
Exploring brain structural effects of dopaminergic antagonism and partial agonism in antipsychotic-naïve patients with first-episode psychosis using normative modeling.
Psychiatry and clinical neurosciences · 2026
Confirmatory factor analysis of competing PANSS negative symptom models: data from OPTiMiSE first-episode schizophrenia study.
BJPsych open · 2025
Using computer vision of facial expressions to assess symptom domains and treatment response in antipsychotic-naïve patients with first-episode psychosis.
Acta psychiatrica Scandinavica · 2025
Functional Connectivity Between Auditory and Medial Temporal Lobe Networks in Antipsychotic-Naïve Patients With First-Episode Schizophrenia Predicts the Effects of Dopamine Antagonism on Auditory Verbal Hallucinations.
Biological psychiatry global open science · 2024

Facts & assertions

0 sourced
No assertions recorded for this entity.